Actively Recruiting
Ototoxicity in Patients With MoM Hip Bearings
Led by Reinier Haga Orthopedisch Centrum · Updated on 2025-03-20
200
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
Sponsors
R
Reinier Haga Orthopedisch Centrum
Lead Sponsor
R
Reinier de Graaf Groep
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patients with high and low plasma metal concentrations.
CONDITIONS
Official Title
Ototoxicity in Patients With MoM Hip Bearings
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients with metal-on-metal hip arthroplasty from the different clinics
- Patients who have had revision metal-on-metal hip arthroplasty
- Willingness to participate in the study
- Ability to speak and write the Dutch language
You will not qualify if you...
- Not willing to participate in the study
- History of previous ear, nose, or throat (ENT) surgery or ENT pathology
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reinier de Graaf Ziekenhuis
Delft, Netherlands
Actively Recruiting
Research Team
N
Nina Mathijssen, Dr
CONTACT
M
Maarten Koper, dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here